Deputy Minister of Industry and Mineral Resources, Osama Al-Zamil, said that the memorandum of understanding signed with the Pfizer Scientific Foundation aims to establish infrastructure in the long term, not just direct manufacturing or commercial production.
In an interview with Al Arabiya, he explained that the memorandum aims to establish a research center to produce different types of vaccines for clinical trials, and to establish production platforms for manufacturing and accelerating the provision of biotechnology vaccines as a basis for building industrial clusters suitable for this promising sector.
And he indicated that there are more than 40 pharmaceutical factories in Saudi Arabia, 3 to 4 of which are ready to manufacture directly with these companies, noting that the factories are conducting direct negotiations with these companies with the support of the government.
He added that work is underway in various directions on the localization of technology, and the ministry will deal with local pharmaceutical manufacturers regarding the commercial aspect.
He stated that the ministry was assigned with this file, as it worked during the past period to analyze and inventory all pharmaceutical industries that achieve pharmaceutical and health security in the Kingdom, and accordingly, it is working in cooperation with government agencies and its international partners to secure these needs, which contributes to the transfer of technology and the localization of vaccine makers.
He pointed out that there are very promising investment activities and opportunities in the pharmaceutical industry in Saudi Arabia, indicating that it seeks to achieve quality investments with these companies and others so that the Saudi market is its first choice for manufacturing in the Middle East.